Abstract:Abstract Background N6-methyladenosine (m6A) RNA methylation plays a critical role in key genetic events for various cancers; yet, how m6A functions within the tumor microenvironment (TME) remains to be elucidated. Methods A total of 65,362 single cells from single-cell RNA-seq data derived from 33 CRC tumor samples were analyzed by nonnegative matrix factorization (NMF) for 23 m6A RNA methylation regulators. CRC and Immunotherapy cohorts from public repository were used to determine the prognosis and immune response of TME clusters. Results The fibroblasts, macrophages, T and B cells were respectively grouped into 4 to 5 subclusters and then classified according to various biological processes and different marker genes. Furthermore, it revealed that the m6A RNA methylation regulators might be significantly related to the clinical and biological features of CRC, as well as the pseudotime trajectories of main TME cell types. Bulk-seq analysis suggested that these m6A-mediated TME cell subclusters had significant prognostic value for CRC patients and distinguished immune response for patients who underwent ICB therapy, especially for the CAFs and macrophages. Notably, CellChat analysis revealed that RNA m6A methylation-associated cell subtypes of TME cells manifested diverse and extensive interaction with tumor epithelial cells. Further analysis showed that ligand-receptor pairs, including MIF − (CD74 + CXCR4), MIF − (CD74 + CD44), MDK–NCL and LGALS9 − CD45, etc. mediated the communication between m6A associated subtypes of TME cells and tumor epithelial cells. Conclusions Taken together, our study firstly revealed the m6A methylation mediated intercellular communication of the tumor microenvironment in the regulation of tumor growth and antitumor immunomodulatory processes.

Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Interaction Between N6-methyladenosine Modification and the Tumor Microenvironment in Colorectal Cancer

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

Single-cell N6-methyladenosine Regulator Patterns Guide Intercellular Communication of Tumor Microenvironment That Contribute to Colorectal Cancer Progression and Immunotherapy

Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment

Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells

N6-methyladenine modification in noncoding RNAs and its function in cancer

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer

The Roles of M6a RNA Modifiers in Human Cancer

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

The Evolving Landscape of N6-methyladenosine Modification in the Tumor Microenvironment.

The Roles of N6-methyladenosine and Its Target Regulatory Noncoding RNAs in Tumors: Classification, Mechanisms, and Potential Therapeutic Implications.

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy

Function of N6-Methyladenosine Modification in Tumors

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing

Role of N6-methyladenosine RNA modification in cancer

N6-methyladenosine links RNA metabolism to cancer progression

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer